ZMC(600216.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
ZMC
600216.SH
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products.
2.788 T
600216.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking89/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.74%C
    • Profit Margin8.52%B
    • Gross Margin35.06%C
  • Growth ScoreD
    • Revenue YoY-6.03%D
    • Net Profit YoY-48.54%D
    • Total Assets YoY1.30%C
    • Net Assets YoY0.88%C
  • Cash ScoreC
    • Cash Flow Margin223.72%B
    • OCF YoY-6.03%D
  • Operating ScoreB
    • Turnover0.63B
  • Debt ScoreA
    • Gearing Ratio19.84%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Shanghai Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend

    Tip Ranks·
    SH
    520690
    -0.97%
    SZ
    159992
    +0.13%
    SH
    589720
    +1.03%
    Tip Ranks·
    SH
    520690
    -0.97%
    SZ
    159992
    +0.13%
    SH
    589720
    +1.03%

    BAIYUNSHAN PH fully acquires ZMC distribution company for a consideration of 500 million RMB

    AASTOCKS·
    SH
    600216
    -2.12%
    SH
    600332
    -1.40%
    HK
    00874
    -0.86%
    AASTOCKS·
    SH
    600216
    -2.12%
    SH
    600332
    -1.40%
    HK
    00874
    -0.86%

    Zhejiang Medicine: State Investment High-Tech plans to reduce its holdings by no more than 1% of shares

    Zhitong·
    SH
    600216
    -2.12%
    Zhitong·
    SH
    600216
    -2.12%

    Zhejiang Medicine released its semi-annual performance, with a net profit attributable to the parent company of 673 million yuan, a year-on-year increase of 113.52%

    Zhitong·
    SH
    600216
    -2.12%
    Zhitong·
    SH
    600216
    -2.12%

    Zhejiang Medicine: Completed the repurchase of 1.43% of shares

    Zhitong·
    SH
    600216
    -2.12%
    Zhitong·
    SH
    600216
    -2.12%
    © 2026 Longbridge｜Disclaimer